{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:15:44Z","timestamp":1795058144970,"version":"4.10.2"},"reference-count":113,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:sec><jats:title>CONTEXT<\/jats:title><jats:p>Idiopathic nephrotic syndrome (INS) in children is a disease with considerable morbidity, yet the incidence and risk for relapse have not been systematically reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>To estimate the overall pooled weighted incidence and risk for relapse of INS in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>DATA SOURCES<\/jats:title><jats:p>Medline and Embase (until December 2020).<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY SELECTION<\/jats:title><jats:p>All studies reporting incidence (per 100\u2009000 children per year) and\/or risk for relapse (the proportion of patients who experience \u22651 relapse) of INS in children (age: &amp;lt;18 years) were eligible.<\/jats:p><\/jats:sec><jats:sec><jats:title>DATA EXTRACTION<\/jats:title><jats:p>After quality assessment, data were extracted: study (design, localization, and sample size) and patient (age, sex, steroid response, and ethnicity) characteristics, incidence, and risk for relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>After screening, 73 studies were included for analysis (27 incidence, 54 relapse). The overall pooled weighted estimate and corresponding prediction interval (PI) of the incidence was 2.92 (95% PI: 0.00\u20136.51) per 100\u2009000 children per year. Higher incidences were found in non-Western countries (P &amp;lt; .001). Incidence tended to be lower in white children, but this was not significant. The overall pooled weighted estimate of the risk for relapse was 71.9% (95% PI: 38.8\u201395.5). Between 1945 and 2011, incidence did not change (P = .39), yet the risk for relapse decreased significantly (P = .024), from 87.4% to 66.2%.<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS<\/jats:title><jats:p>There was no full-text availability (n = 33), considerable heterogeneity, and limited studies from Africa, Latin America, and Asia.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>INS has a low incidence with ethnic variation but high risk for relapse. Although corticosteroids have significantly reduced the risk for relapse, it remains unacceptably high, underscoring the need for alternative treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2020-029249","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T08:26:26Z","timestamp":1625041586000},"source":"Crossref","is-referenced-by-count":87,"title":["Incidence and Relapse of Idiopathic Nephrotic Syndrome: Meta-analysis"],"prefix":"10.1542","volume":"148","author":[{"given":"Floor","family":"Veltkamp","sequence":"first","affiliation":[{"name":"Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie R.","family":"Rensma","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia H. M.","family":"Bouts","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"2","key":"2021121007541563100_B1","first-page":"139","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","author":"Kidney Disease Improving Global Outcomes","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"2021121007541563100_B2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1978.23","article-title":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis","volume":"13","author":"International Study of Kidney Disease in Children","year":"1978","journal-title":"Kidney Int"},{"key":"2021121007541563100_B3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/978-3-540-76341-3_28","article-title":"Idiopathic nephrotic syndrome in children: clinical aspects","volume-title":"Pediatric Nephrology","author":"Niaudet","year":"2009","edition":"6th ed."},{"issue":"7212","key":"2021121007541563100_B4","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(61)91026-1","article-title":"164 children with nephrosis","volume":"2","author":"Arneil","year":"1961","journal-title":"Lancet"},{"key":"2021121007541563100_B5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fped.2016.00056","article-title":"History of nephrotic syndrome and evolution of its treatment","volume":"4","author":"Pal","year":"2016","journal-title":"Front Pediatr"},{"issue":"162","key":"2021121007541563100_B6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/adc.32.162.99","article-title":"The natural history of nephrosis","volume":"32","author":"Todd","year":"1957","journal-title":"Arch Dis Child"},{"issue":"9384","key":"2021121007541563100_B7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"2021121007541563100_B8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2021121007541563100_B9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00467-011-1851-8","article-title":"Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature","volume":"26","author":"El Bakkali","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"7468","key":"2021121007541563100_B10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(66)92253-7","article-title":"Long-term assessment of steroid therapy in childhood nephrosis","volume":"2","author":"Arneil","year":"1966","journal-title":"Lancet"},{"issue":"4","key":"2021121007541563100_B11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1542\/peds.73.4.497","article-title":"Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years\u2019 observation","volume":"73","author":"International Study of Kidney Disease in Children","year":"1984","journal-title":"Pediatrics"},{"issue":"3","key":"2021121007541563100_B12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0031-3955(16)30270-X","article-title":"Childhood nephrosis","volume":"58","author":"Riley","year":"1955","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"2021121007541563100_B13","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00467-015-3106-6","article-title":"Corticosteroids for the initial episode of steroid-sensitive nephrotic syndrome","volume":"30","author":"Hodson","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"2021121007541563100_B14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone","volume":"98","author":"International Study of Kidney Disease in Children","year":"1981","journal-title":"J Pediatr"},{"issue":"1","key":"2021121007541563100_B15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10157-017-1433-6","article-title":"The incidence of the nephrotic syndrome in childhood in Germany","volume":"22","author":"Franke","year":"2018","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"2021121007541563100_B16","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00467-016-3509-z","article-title":"Epidemiology of idiopathic nephrotic syndrome in children: endemic or epidemic?","volume":"31","author":"Dossier","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"2021121007541563100_B17","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2215\/CJN.00380116","article-title":"Ethnic differences in incidence and outcomes of childhood nephrotic syndrome","volume":"11","author":"Banh","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"2021121007541563100_B18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s004670100021","article-title":"Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK","volume":"16","author":"McKinney","year":"2001","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2021121007541563100_B19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/adc.60.11.1018","article-title":"High incidence of minimal change nephrotic syndrome in Asians","volume":"60","author":"Feehally","year":"1985","journal-title":"Arch Dis Child"},{"issue":"7","key":"2021121007541563100_B20","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"15","key":"2021121007541563100_B21","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"2021121007541563100_B22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"3","key":"2021121007541563100_B23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ije\/dym018","article-title":"Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography","volume":"36","author":"Sanderson","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2021121007541563100_B24","first-page":"170","article-title":"Critical appraisal of the health research literature: prevalence or incidence of a health problem","volume":"19","author":"Loney","year":"1998","journal-title":"Chronic Dis Can"},{"key":"2021121007541563100_B25","unstructured":"Viswanathan\u2008M, Ansari\u2008MT, Berkman\u2008ND, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality Methods Guide for Comparative Effectiveness Reviews; 2012. Available at: www.effectivehealthcare.ahrq.gov. Accessed June 2, 2021"},{"key":"2021121007541563100_B26","doi-asserted-by":"crossref","unstructured":"Higgins\u2008JPT, Thomas\u2008J, Elbers\u2008RG, Sterne\u2008JAC. Assessing risk of bias in a randomized trial. In: Higgins\u2008JPT, Thomas\u2008J, Chandler\u2008J, et al, eds.\u2008Cochrane Handbook for Systematic Reviews of Interventions Version 6.0. London, United Kingdom: Cochrane; 2019. Available at: www.training.cochrane.org\/handbook. Accessed June 2, 2021","DOI":"10.1002\/9781119536604.ch8"},{"key":"2021121007541563100_B27","doi-asserted-by":"crossref","unstructured":"Sterne\u2008JAC, Hern\u00e1n\u2008MA, McAleenan\u2008A, Reeves\u2008BC, Higgins\u2008JPT. Assessing risk of bias in a non-randomized study. In: Higgins\u2008JPT, Thomas\u2008J, Chandler\u2008J, et al, eds.\u2008Cochrane Handbook for Systematic Reviews of Interventions Version 6.0. London, United Kingdom: Cochrane; 2019. Available at: www.training.cochrane.org\/handbook. Accessed June 2, 2021","DOI":"10.1002\/9781119536604.ch25"},{"key":"2021121007541563100_B28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jclinepi.2017.12.009","article-title":"Systematic review of current guideline appraisals performed with the Appraisal of Guidelines for Research & Evaluation II instrument-a third of AGREE II users apply a cut-off for guideline quality","volume":"95","author":"Hoffmann-E\u00dfer","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"2021121007541563100_B29","volume-title":"World Development Indicators","author":"The World Bank","year":"2020"},{"key":"2021121007541563100_B30","doi-asserted-by":"crossref","unstructured":"Deeks\u2008JJ, Higgins\u2008JPT, Altman\u2008DG. Analysing data and undertaking meta-analyses. In: Higgins\u2008JPT, Thomas\u2008J, Chandler\u2008J, et al, eds.\u2008Cochrane Handbook for Systematic Reviews of Interventions Version 6.0. London, United Kingdom: Cochrane; 2019. Available at: www.training.cochrane.org\/handbook. Accessed June 2, 2021","DOI":"10.1002\/9781119536604.ch10"},{"key":"2021121007541563100_B31","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2019"},{"issue":"3","key":"2021121007541563100_B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metaphor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"5","key":"2021121007541563100_B33","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4103\/1319-2442.118096","article-title":"Patterns of childhood nephrotic syndrome in Aljouf region, Saudi Arabia","volume":"24","author":"Alhassan","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"12","key":"2021121007541563100_B34","first-page":"1977","article-title":"Childhood nephrotic syndrome: change in pattern and response to steroids","volume":"98","author":"Anochie","year":"2006","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"2021121007541563100_B35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.arcped.2011.02.012","article-title":"Syndrome n\u00e9phrotique idiopathique de l\u2019enfant: incidence, pr\u00e9sentation clinique et devenir dans le d\u00e9partement de la Gironde, France","volume":"18","author":"Ernould","year":"2011","journal-title":"Arch Pediatr"},{"issue":"4","key":"2021121007541563100_B36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10157-016-1319-z","article-title":"High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study)","volume":"21","author":"Kikunaga","year":"2017","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"2021121007541563100_B37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00467-013-2736-9","article-title":"Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study","volume":"29","author":"Sureshkumar","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2021121007541563100_B38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1440-1754.2007.01077.x","article-title":"Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study","volume":"43","author":"Wong","year":"2007","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"2021121007541563100_B39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00852914","article-title":"Primary nephrotic syndrome in Arab children in Kuwait","volume":"3","author":"Zaki","year":"1989","journal-title":"Pediatr Nephrol"},{"key":"2021121007541563100_B40","first-page":"26","article-title":"Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome","volume":"41","author":"\u010cerkauskien\u0117","year":"2005","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"2021121007541563100_B41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2188\/jea.JE20120033","article-title":"Epidemiology and predictors of end-stage renal disease in Taiwanese children with idiopathic nephrotic syndrome","volume":"22","author":"Chang","year":"2012","journal-title":"J Epidemiol"},{"issue":"5","key":"2021121007541563100_B42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2021121007541563100_B43","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-3476(82)80692-6","article-title":"Early identification of frequent relapsers among children with minimal change nephrotic syndrome","volume":"101","author":"International Study of Kidney Disease in Children","year":"1982","journal-title":"J Pediatr"},{"issue":"6","key":"2021121007541563100_B44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1442-200X.2002.01628.x","article-title":"Childhood idiopathic nephrotic syndrome in Turkey","volume":"44","author":"Bircan","year":"2002","journal-title":"Pediatr Int"},{"issue":"5","key":"2021121007541563100_B45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bmhimx.2016.07.005","article-title":"Estudio comparativo entre el esquema convencional y el tratamiento prolongado con esteroides en el s\u00edndrome nefr\u00f3tico cortico-sensible primario en Pediatr\u00eda","volume":"73","author":"Liern","year":"2016","journal-title":"Bol M\u00e9d Hosp Infant M\u00e9xico"},{"issue":"3","key":"2021121007541563100_B46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/adc.59.3.253","article-title":"Primary nephrotic syndrome in Arab children","volume":"59","author":"Elzouki","year":"1984","journal-title":"Arch Dis Child"},{"issue":"4","key":"2021121007541563100_B47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00431-013-2192-3","article-title":"A prospective randomly controlled clinical trial on azithromycin therapy for induction treatment of children with nephrotic syndrome","volume":"173","author":"Zhang","year":"2014","journal-title":"Eur J Pediatr"},{"key":"2021121007541563100_B48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic differences in childhood nephrotic syndrome","volume":"4","author":"Chanchlani","year":"2016","journal-title":"Front Pediatr"},{"issue":"1","key":"2021121007541563100_B49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-3476(88)80136-7","article-title":"Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome","volume":"112","author":"Ueda","year":"1988","journal-title":"J Pediatr"},{"issue":"4","key":"2021121007541563100_B50","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00467-018-4149-2","article-title":"Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study","volume":"34","author":"Dossier","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2021121007541563100_B51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2021121007541563100_B52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jrsm.1348","article-title":"Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions","volume":"10","author":"Schwarzer","year":"2019","journal-title":"Res Synth Methods"},{"key":"2021121007541563100_B53","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"7","key":"2021121007541563100_B54","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"2021121007541563100_B55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s004670050555","article-title":"High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood","volume":"13","author":"Srivastava","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"2021121007541563100_B56","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00467-010-1537-7","article-title":"Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome","volume":"25","author":"Andersen","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2021121007541563100_B57","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2021121007541563100_B58","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1681\/ASN.2014030247","article-title":"HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome","volume":"26","author":"Gbadegesin","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2021121007541563100_B59","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/j.ajkd.2017.10.013","article-title":"HLA-DQA1 and APOL1 as risk loci for childhood-onset steroid-sensitive and steroid-resistant nephrotic syndrome","volume":"71","author":"Adeyemo","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"2021121007541563100_B60","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1681\/ASN.2017080859","article-title":"Strong association of the HLA-DR\/DQ locus with childhood steroid-sensitive nephrotic syndrome in the Japanese population","volume":"29","author":"Jia","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2021121007541563100_B61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1399-0039.1994.tb02340.x","article-title":"HLA class II associations with idiopathic nephrotic syndrome in children","volume":"43","author":"Konrad","year":"1994","journal-title":"Tissue Antigens"},{"issue":"7","key":"2021121007541563100_B62","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1681\/ASN.2017111185","article-title":"Transethnic, genome-wide analysis reveals immune-related risk alleles and phenotypic correlates in pediatric steroid-sensitive nephrotic syndrome","volume":"29","author":"Debiec","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2021121007541563100_B63","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000188540","article-title":"Association of DQB1*0302 alloantigens in Japanese pediatric patients with steroid-sensitive nephrotic syndrome","volume":"70","author":"Abe","year":"1995","journal-title":"Nephron"},{"issue":"9","key":"2021121007541563100_B64","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/nep.12669","article-title":"Association of HLA-DR\/DQ alleles and haplotypes with nephrotic syndrome","volume":"21","author":"Ramanathan","year":"2016","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"2021121007541563100_B65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2014.240","article-title":"Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome","volume":"87","author":"Sinha","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"2021121007541563100_B66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney Int"},{"key":"2021121007541563100_B67","doi-asserted-by":"crossref","first-page":"l1800","DOI":"10.1136\/bmj.l1800","article-title":"Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation","volume":"365","author":"Webb","year":"2019","journal-title":"BMJ"},{"issue":"8","key":"2021121007541563100_B68","doi-asserted-by":"crossref","first-page":"e027011","DOI":"10.1136\/bmjopen-2018-027011","article-title":"Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study)","volume":"9","author":"Veltkamp","year":"2019","journal-title":"BMJ Open"},{"issue":"10","key":"2021121007541563100_B69","doi-asserted-by":"crossref","first-page":"e024882","DOI":"10.1136\/bmjopen-2018-024882","article-title":"Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone: protocol for a randomised, controlled, multicentre trial (INTENT study)","volume":"8","author":"Ehren","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"2021121007541563100_B70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","article-title":"Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","volume":"95","author":"Sinha","year":"2019","journal-title":"Kidney Int"},{"issue":"49","key":"2021121007541563100_B71","first-page":"3043","article-title":"Nefrotisk syndrom hos b\u00f8rn. Efterunders\u00f8gelse af 23 patienter","volume":"140","author":"Agner","year":"1978","journal-title":"Ugeskr Laeger"},{"issue":"1","key":"2021121007541563100_B72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpam.2017.12.004","article-title":"A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center","volume":"5","author":"Al Talhi","year":"2018","journal-title":"Int J Pediatr Adolesc Med"},{"issue":"2","key":"2021121007541563100_B73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0009922816645521","article-title":"Patterns of childhood steroid-sensitive and steroid-resistant nephrotic syndrome in Saudi children","volume":"56","author":"Alharthi","year":"2017","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"2021121007541563100_B74","first-page":"851","article-title":"Childhood idiopathic steroid-resistant nephrotic syndrome at a single center in Khartoum","volume":"28","author":"Ali","year":"2017","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"8","key":"2021121007541563100_B75","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1111\/apa.12647","article-title":"The challenges of caring for children with nephrotic syndrome in a tertiary institution in the Democratic Republic of Congo","volume":"103","author":"Aloni","year":"2014","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021121007541563100_B76","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00365599509180533","article-title":"Outcome of idiopathic childhood nephrotic syndrome. A 20 year experience","volume":"29","author":"Andenmatten","year":"1995","journal-title":"Scand J Urol Nephrol"},{"issue":"9","key":"2021121007541563100_B77","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004670050708","article-title":"Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome","volume":"13","author":"Bagga","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2021121007541563100_B78","first-page":"116","article-title":"Idiopathic nephrotic syndrome in children: review of 282 Croatian cases","volume":"78","author":"Batini\u0107","year":"2012","journal-title":"Clin Nephrol"},{"issue":"2","key":"2021121007541563100_B79","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0272-6386(87)80087-2","article-title":"Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth","volume":"9","author":"Berns","year":"1987","journal-title":"Am J Kidney Dis"},{"issue":"15","key":"2021121007541563100_B80","first-page":"939","article-title":"Incidence of nephrotic syndrome in paediatric age over the last ten years. Therapeutic results obtained with the use of three corticosteroids [in Italian]","volume":"32","author":"Bosco Berghesan","year":"1980","journal-title":"Minerva Pediatr"},{"key":"2021121007541563100_B81","article-title":"Epidemiology of idiopathic nephrotic syndrome. A prospective study in to French areas","author":"Bouissou"},{"issue":"3","key":"2021121007541563100_B82","first-page":"457","article-title":"Primary nephrotic syndrome. Follow-up of 202 pediatric patients [in Spanish]","volume":"38","author":"Caletti","year":"1981","journal-title":"Bol M\u00e9d Hosp Infant M\u00e9xico"},{"issue":"8","key":"2021121007541563100_B83","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3109\/0886022X.2015.1073051","article-title":"The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome","volume":"37","author":"Din\u00e7el","year":"2015","journal-title":"Ren Fail"},{"issue":"3","key":"2021121007541563100_B84","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gfi297","article-title":"Nephrotic syndrome in African children: lack of evidence for \u2018tropical nephrotic syndrome\u2019?","volume":"21","author":"Doe","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2021121007541563100_B85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01956754","article-title":"Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children","volume":"152","author":"Ehrich","year":"1993","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2021121007541563100_B86","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/1119-3077.164326","article-title":"Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome","volume":"19","author":"Esezobor","year":"2016","journal-title":"Niger J Clin Pract"},{"issue":"7","key":"2021121007541563100_B87","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00467-011-1837-6","article-title":"Clinical course and outcome of children with steroid-sensitive nephrotic syndrome","volume":"26","author":"Esfahani","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2021121007541563100_B88","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.ajkd.2003.08.010","article-title":"Is there really an increase in non-minimal change nephrotic syndrome in children?","volume":"42","author":"Filler","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2021121007541563100_B89","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0272-6386(03)00346-9","article-title":"A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children","volume":"41","author":"Hiraoka","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2021121007541563100_B90","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2005090922","article-title":"Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial","volume":"17","author":"Hoyer","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2021121007541563100_B91","first-page":"235","article-title":"Epidemiology and clinicopathologic characteristics of childhood nephrotic syndrome in Benin-City, Nigeria","volume":"48","author":"Ibadin","year":"1998","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"2021121007541563100_B92","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1523-1755.2005.00524.x","article-title":"High incidence of initial and late steroid resistance in childhood nephrotic syndrome","volume":"68","author":"Kim","year":"2005","journal-title":"Kidney Int"},{"issue":"7","key":"2021121007541563100_B93","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","article-title":"Long-term outcome of primary nephrotic syndrome","volume":"57","author":"Koskimies","year":"1982","journal-title":"Arch Dis Child"},{"issue":"8","key":"2021121007541563100_B94","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1651-2227.1995.tb13787.x","article-title":"Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children","volume":"84","author":"Ksi\u0105\u017cek","year":"1995","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021121007541563100_B95","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00467-002-1052-6","article-title":"Long versus standard initial steroid therapy for children with the nephrotic syndrome. A report from the Southwest Pediatric Nephrology Study Group","volume":"18","author":"Lande","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"2021121007541563100_B96","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000415405","article-title":"Steroid-sensitive minimal change nephrotic syndrome. Long-term follow-up","volume":"67","author":"Lewis","year":"1988","journal-title":"Contrib Nephrol"},{"issue":"6","key":"2021121007541563100_B97","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/archpedi.1974.02110250056008","article-title":"The idiopathic nephrotic syndrome of childhood. A clinical reevaluation of 148 cases","volume":"127","author":"Makker","year":"1974","journal-title":"Am J Dis Child"},{"issue":"5","key":"2021121007541563100_B98","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF00869837","article-title":"Nephrotic syndrome in Saudi children clinicopathological study of 150 cases","volume":"4","author":"Mattoo","year":"1990","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"2021121007541563100_B99","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nefro.2017.11.022","article-title":"Predictors of poor outcome in children with steroid sensitive nephrotic syndrome [in English, Spanish]","volume":"38","author":"Mishra","year":"2018","journal-title":"Nefrologia"},{"key":"2021121007541563100_B100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/TCRM.S19751","article-title":"Steroid response pattern and outcome of pediatric idiopathic nephrotic syndrome: a single-center experience in northwest Iran","volume":"7","author":"Mortazavi","year":"2011","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"2021121007541563100_B101","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.09010912","article-title":"Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome","volume":"8","author":"Nakanishi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"2021121007541563100_B102","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.arcped.2016.03.008","article-title":"Le syndrome n\u00e9phrotique de l\u2019enfant au centre hospitalier universitaire de Dakar","volume":"23","author":"Ndongo","year":"2016","journal-title":"Arch Pediatr"},{"issue":"4","key":"2021121007541563100_B103","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/0886022X.2015.1010940","article-title":"Long-term prognosis of idiopathic nephrotic syndrome in children","volume":"37","author":"\u00d6zl\u00fc","year":"2015","journal-title":"Ren Fail"},{"issue":"6","key":"2021121007541563100_B104","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/ejhpharm-2013-000300","article-title":"Paediatric nephrotic syndrome: prednisolone treatment adherence and short-term outcomes","volume":"20","author":"Panda","year":"2013","journal-title":"Eur J Hosp Pharm Sci Pract"},{"issue":"3","key":"2021121007541563100_B105","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1542\/peds.19.3.446","article-title":"The incidence of the nephrotic syndrome in children","volume":"19","author":"Rothenberg","year":"1957","journal-title":"Pediatrics"},{"issue":"3","key":"2021121007541563100_B106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0971-4065.57103","article-title":"Spectrum of childhood nephrotic syndrome in Iran: a single center study","volume":"19","author":"Safaei","year":"2009","journal-title":"Indian J Nephrol"},{"issue":"6","key":"2021121007541563100_B107","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/archpedi.1968.02100020627009","article-title":"The nephrotic syndrome. Its incidence and implications for the community","volume":"116","author":"Schlesinger","year":"1968","journal-title":"Am J Dis Child"},{"issue":"11","key":"2021121007541563100_B108","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/adc.60.11.1014","article-title":"Steroid responsive nephrotic syndrome is more common in Asians","volume":"60","author":"Sharples","year":"1985","journal-title":"Arch Dis Child"},{"issue":"2","key":"2021121007541563100_B109","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3476(72)80291-9","article-title":"Long-term follow-up of children with steroid-responsive nephrotic syndrome","volume":"81","author":"Siegel","year":"1972","journal-title":"J Pediatr"},{"issue":"2","key":"2021121007541563100_B110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.5414\/CN107381","article-title":"Has the incidence of childhood steroid sensitive nephrotic syndrome changed?","volume":"78","author":"Spencer","year":"2012","journal-title":"Clin Nephrol"},{"issue":"5","key":"2021121007541563100_B111","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0021-9681(58)90106-1","article-title":"An epidemiologic study of the nephrotic syndrome","volume":"7","author":"Stickler","year":"1958","journal-title":"J Chronic Dis"},{"issue":"6","key":"2021121007541563100_B112","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jpeds.2009.12.020","article-title":"Time for initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome","volume":"156","author":"Vivarelli","year":"2010","journal-title":"J Pediatr"},{"issue":"2","key":"2021121007541563100_B113","first-page":"63","article-title":"Current estimates of the incidence of steroid responsive idiopathic nephrosis in Kentucky children 1-9 years of age","volume":"3","author":"Wyatt","year":"1982","journal-title":"Int J Pediatr Nephrol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-029249\/1182305\/peds_2020029249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-029249\/1182305\/peds_2020029249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T02:52:23Z","timestamp":1672627943000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/148\/1\/e2020029249\/179943\/Incidence-and-Relapse-of-Idiopathic-Nephrotic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,7,1]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-029249","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"e2020029249"}}